Accessibility Menu
Phreesia Stock Quote

Phreesia (NYSE: PHR)

$17.02
(1.2%)
+0.21
Price as of December 26, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$17.02
Daily Change
(1.2%) +$0.21
Day's Range
$16.65 - $17.13
Previous Close
$17.02
Open
$16.70
Beta
1.64
Volume
529,990
Average Volume
1,054,887
Market Cap
$1.0B
Market Cap / Employee
$17.02M
52wk Range
$15.41 - $32.76
Revenue
N/A
Gross Margin
0.62%
Dividend Yield
N/A
EPS
-$0.10
CAPs Rating
N/A
Industry
Health Care Technology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Phreesia Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
PHR-33.93%-70.3%-21.53%-32%
S&P+14.78%+87.14%+13.33%+131%
Advertisement

Phreesia Company Info

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

News & Analysis

Financial Health

General

Q4 2025YOY Change
Revenue$120.33M12.7%
Gross Profit$74.72M17.0%
Gross Margin62.09%2.3%
Market Cap$1.36B28.4%
Market Cap / Employee$651.52K0.0%
Employees2.1K44.8%
Net Income$4.27M129.7%
EBITDA$13.30M344.8%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q4 2025YOY Change
Net Cash$106.37M30.1%
Accounts Receivable$88.26M23.6%
Inventory00.0%

Liabilities

Q4 2025YOY Change
Long Term Debt$3.49M-68.7%
Short Term Debt$6.95M-29.8%

Ratios

Q4 2025YOY Change
Return On Assets-1.35%20.7%
Return On Invested Capital-34.60%-1.0%

Cash Flow

Q4 2025YOY Change
Free Cash Flow$12.18M135.6%
Operating Free Cash Flow$15.45M167.1%

Valuation

MetricQ1 2025Q2 2025Q3 2025Q4 2025YoY Change
Price to Book6.495.545.684.548.14%
Price to Sales3.953.383.703.0115.13%
Price to Tangible Book Value16.8013.5712.779.54-13.38%
Price to Free Cash Flow TTM70.5240.2138.6727.86-87.46%
Enterprise Value to EBITDA-2341.43377.10256.7797.57-153.12%
Free Cash Flow Yield1.4%2.5%2.6%3.6%697.68%
Return on Equity-22.7%-16.0%-8.8%-1.9%-94.13%
Total Debt$17.80M$15.87M$12.79M$10.43M-50.38%
Advertisement

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.